Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jun;6(2):125-9.
doi: 10.1007/s11523-011-0174-9. Epub 2011 Apr 16.

Common toxicities of mammalian target of rapamycin inhibitors

Affiliations
Review

Common toxicities of mammalian target of rapamycin inhibitors

Scott A Soefje et al. Target Oncol. 2011 Jun.

Abstract

The toxicities of newer targeted therapies are different from those seen with the traditional chemotherapy. Mammalian target of rapamycin (mTOR) inhibitors are evolving into an important class of drugs in oncology, and this class of drugs presents with a variety of different toxicities. Although similar to the toxicities seen in transplantation, these rapamycin analogs have unique side effects when compared to traditional chemotherapy agents. While most of the toxicities are mild, few can be severe and require routine monitoring. Mucositis and rash are the most common side effects. The metabolic toxicities, hyperglycemia, hyperlipidemia, and hypophosphatemia are different from the side effects traditionally seen with chemotherapy. This review will focus on the common toxicities seen with the mTOR inhibitors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1999 Nov 12;274(46):33085-91 - PubMed
    1. Transplantation. 2004 Apr 27;77(8):1215-20 - PubMed
    1. Transplantation. 2005 Feb 27;79(4):476-82 - PubMed
    1. Transplantation. 1998 May 15;65(9):1272-4 - PubMed
    1. Am J Med. 2005 Oct;118(10):1094-101 - PubMed

Publication types

MeSH terms

LinkOut - more resources